CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-18 | Miller Joseph M Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2020-06-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +28,000 | $2.44 | $68K | 1,128,000 |
| 2020-06-10 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +6,391 | $2.28 | $15K | 28,009 |
| 2020-06-10 | Sullivan Christopher Ryan Interim CFO | Purchase | +2,954 | $2.28 | $7K | 2,954 |
| 2020-06-10 | NEIL GARRY ARTHUR Chief Scientific Officer | Purchase | +1,799 | $2.28 | $4K | 74,081 |
| 2020-06-09 | Harrell James Archie Jr Chief Commercial Officer | Purchase | +10,000 | $2.50 | $25K | 21,618 |
| 2020-06-09 | COLA MICHAEL F Chief Executive Officer | Purchase | +100,000 | $2.50 | $250K | 175,746 |
| 2020-06-09 | ARMISTICE CAPITAL, LLC Director | Purchase | +1,753,680 | $2.50 | $4.4M | 29,914,285 |
| 2020-06-09 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 29,914,285 | ||
| 2020-06-09 | ARMISTICE CAPITAL, LLC Director | Purchase | +267,806 | $2.52 | $675K | 1,100,000 |
| 2020-06-08 | Miller Joseph M Director | Shares withheld for taxes | −4,472 | $3.22 | $14K | 40,582 |
| 2020-04-24 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-04-09 | Pedder Simon Executive Chairman of the Bd | Shares withheld for taxes | −20,901 | $2.57 | $54K | 241,833 |
| 2020-04-09 | Miller Joseph M Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2020-04-09 | Harrell James Archie Jr Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +268,000 | 268,000 | ||
| 2020-04-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +4,280 | $2.16 | $9K | 832,194 |
| 2020-03-31 | Persson Magnus Director | Grant or award · Stock Option (Right to Buy) | +4,866 | 4,866 | ||
| 2020-03-31 | Hacksell Uli Director | Grant or award · Stock Option (Right to Buy) | +2,007 | 2,007 | ||
| 2020-03-31 | Gutry Phil Director | Grant or award · Stock Option (Right to Buy) | +4,310 | 4,310 | ||
| 2020-03-31 | ARMISTICE CAPITAL, LLC Director | Purchase | +26,611 | $2.33 | $62K | 827,914 |
Page 21 of 25 · 500 trades